Drug-Prices Investigation Focused on Middlemen Opens in Congress

msevcik1
Mar 1, 2023
1 min read

House Republicans have launched an investigation into the companies that manage drug benefits, dialing up the scrutiny of the middlemen who play an important role in how much medicines cost.

Read the full story >

Recent Posts

See All

Experts weigh in on Trump reversing Biden's order to lower drug prices

During his presidency, Joe Biden had directed Medicare to look at ways to lower drug costs, including whether or not to impose a two...

FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

PBMs are ‘charging enormous markups on dozens of lifesaving drugs,’ an agency official said. For the second time in less than a year, the...

‘Customers are panicking’; Pharmacists make their case for reining in pharmacy benefit managers

Pharmacy benefit managers, or PBMs, are squeezing independent pharmacies out of the drug market, according to pharmacists who recently...

Drug-Prices Investigation Focused on Middlemen Opens in Congress

Recent Posts

Comments

info@pbmaccountabilityoh.org

@PBMprojectOH

CONTACT US

PBM Accountability Project of Ohio. © 2020. All Rights Reserved.